Foldrx Pharmaceuticals
Cambridge · Founded 2003
About Foldrx Pharmaceuticals
FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The company¢s pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson's disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.
Company Facts
- Founded: 2003
- Legal name: FoldRx Pharmaceuticals, Inc.
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $88.0M
- Funding stage: M&A
- Last round: Series Unknown (Jun 2010)
- Website: foldrx.com
- Phone: +1 617-252-5500
Social Profiles
Canonical: https://fsome.com/organization/foldrx-pharmaceuticals-8364593 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.